Spraker Matthew B, Wootton Landon S, Hippe Daniel S, Ball Kevin C, Peeken Jan C, Macomber Meghan W, Chapman Tobias R, Hoff Michael N, Kim Edward Y, Pollack Seth M, Combs Stephanie E, Nyflot Matthew J
Department of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri.
Department of Radiation Oncology, University of Washington, Seattle, Washington.
Adv Radiat Oncol. 2019 Feb 23;4(2):413-421. doi: 10.1016/j.adro.2019.02.003. eCollection 2019 Apr-Jun.
Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of individualized treatments remains a challenge. The goal of this study was to determine whether radiomic features extracted from magnetic resonance (MR) images are independently associated with overall survival (OS) in STS.
This study analyzed 2 independent cohorts of adult patients with stage II-III STS treated at center 1 (N = 165) and center 2 (N = 61). Thirty radiomic features were extracted from pretreatment T1-weighted contrast-enhanced MR images. Prognostic models for OS were derived on the center 1 cohort and validated on the center 2 cohort. Clinical-only (C), radiomics-only (R), and clinical and radiomics (C+R) penalized Cox models were constructed. Model performance was assessed using Harrell's concordance index.
In the R model, tumor volume (hazard ratio [HR], 1.5) and 4 texture features (HR, 1.1-1.5) were selected. In the C+R model, both age (HR, 1.4) and grade (HR, 1.7) were selected along with 5 radiomic features. The adjusted c-indices of the 3 models ranged from 0.68 (C) to 0.74 (C+R) in the derivation cohort and 0.68 (R) to 0.78 (C+R) in the validation cohort. The radiomic features were independently associated with OS in the validation cohort after accounting for age and grade (HR, 2.4; = .009).
This study found that radiomic features extracted from MR images are independently associated with OS when accounting for age and tumor grade. The overall predictive performance of 3-year OS using a model based on clinical and radiomic features was replicated in an independent cohort. Optimal models using clinical and radiomic features could improve personalized selection of therapy in patients with STS.
软组织肉瘤(STS)是一组异质性疾病,选择个体化治疗仍然是一项挑战。本研究的目的是确定从磁共振(MR)图像中提取的放射组学特征是否与STS患者的总生存期(OS)独立相关。
本研究分析了在中心1(N = 165)和中心2(N = 61)接受治疗的2个独立队列的II - III期成年STS患者。从治疗前的T1加权对比增强MR图像中提取30个放射组学特征。在中心1队列中推导OS的预后模型,并在中心2队列中进行验证。构建了仅临床(C)、仅放射组学(R)以及临床和放射组学(C + R)的惩罚Cox模型。使用Harrell一致性指数评估模型性能。
在R模型中,选择了肿瘤体积(风险比[HR],1.5)和4个纹理特征(HR,1.1 - 1.5)。在C + R模型中,年龄(HR,1.4)和分级(HR,1.7)以及5个放射组学特征均被选中。在推导队列中,3个模型的校正c指数范围为0.68(C)至0.74(C + R),在验证队列中为0.68(R)至0.78(C + R)。在考虑年龄和分级后,放射组学特征在验证队列中与OS独立相关(HR,2.4;P = 0.009)。
本研究发现,在考虑年龄和肿瘤分级时,从MR图像中提取的放射组学特征与OS独立相关。基于临床和放射组学特征的模型对3年OS的总体预测性能在独立队列中得到了重复验证。使用临床和放射组学特征的最佳模型可改善STS患者的个性化治疗选择。